Marine Fidelle
Overview
Explore the profile of Marine Fidelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
3014
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Levy A, Tian A, Huang X, Cai G, Fidelle M, et al.
Cancer Cell
. 2025 Mar;
43(3):361-379.e10.
PMID: 40068595
The mechanisms governing the abscopal effects of local radiotherapy in cancer patients remain an open conundrum. Here, we show that off-target intestinal low-dose irradiation (ILDR) increases the clinical benefits of...
2.
Tian A, Leduc M, Fidelle M, Zitvogel L, Kroemer G, Kepp O
Methods Cell Biol
. 2025 Mar;
194:119-133.
PMID: 40058956
Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) expression in high endothelial venules is regulated by bacterial metabolites emanating from the gut and the interaction of MAdCAM-1 with α4β7 integrin mediates...
3.
Montegut L, Liu P, Zhao L, Perez-Lanzon M, Chen H, Mao M, et al.
Mol Cancer
. 2024 Oct;
23(1):231.
PMID: 39420364
No abstract available.
4.
5.
Alves Costa Silva C, Fidelle M, Almonte A, Derosa L, Zitvogel L
Annu Rev Pharmacol Toxicol
. 2024 Sep;
65(1):333-354.
PMID: 39259979
Carcinogenesis is associated with the emergence of protracted intestinal dysbiosis and metabolic changes. Increasing evidence shows that gut microbiota-related biomarkers and microbiota-centered interventions are promising strategies to overcome resistance to...
6.
Montegut L, Liu P, Zhao L, Perez-Lanzon M, Chen H, Mao M, et al.
Mol Cancer
. 2024 Sep;
23(1):187.
PMID: 39242519
Background: The plasma concentrations of acyl coenzyme A binding protein (ACBP, also known as diazepam-binding inhibitor, DBI, or 'endozepine') increase with age and obesity, two parameters that are also amongst...
7.
Zitvogel L, Fidelle M, Kroemer G
Immunity
. 2024 Aug;
57(9):2013-2029.
PMID: 39151425
The intestinal microbiota determines immune responses against extraintestinal antigens, including tumor-associated antigens. Indeed, depletion or gross perturbation of the microbiota undermines the efficacy of cancer immunotherapy, thereby compromising the clinical...
8.
Derosa L, Iebba V, Alves Costa Silva C, Piccinno G, Wu G, Lordello L, et al.
Cell
. 2024 Jun;
187(13):3373-3389.e16.
PMID: 38906102
The gut microbiota influences the clinical responses of cancer patients to immunecheckpoint inhibitors (ICIs). However, there is no consensus definition of detrimental dysbiosis. Based on metagenomics (MG) sequencing of 245...
9.
Alves Costa Silva C, Piccinno G, Suissa D, Bourgin M, Schreibelt G, Durand S, et al.
Nat Commun
. 2024 Feb;
15(1):1633.
PMID: 38395948
Tumor immunosurveillance plays a major role in melanoma, prompting the development of immunotherapy strategies. The gut microbiota composition, influencing peripheral and tumoral immune tonus, earned its credentials among predictors of...
10.
Fidelle M, Tian A, Zitvogel L, Kroemer G
Oncoimmunology
. 2023 Jul;
12(1):2224672.
PMID: 37405191
In a recent paper in , Fidelle et al. unravel a gut immune checkpoint that is subverted by antibiotic treatment. Post-antibiotic dysbiosis of the ileum causes an increase in bile...